The FY2023 (Dec) proxy of Zentalis Pharmaceuticals names 23 peer companies for pay. Pay versus performance data of Zentalis Pharmaceuticals for that year is not on file, so it has no rank.
Pay peer group, FY2023 (Dec) proxy
| Relay Therapeutics | ||
| Allogene Therapeutics | ||
| CRISPR Therapeutics AG | ||
| Arcus Biosciences | ||
| Kymera Therapeutics | ||
| Cytokinetics | ||
| Celldex Therapeutics | ||
| Denali Therapeutics | ||
| Arvinas | ||
| Beam Therapeutics | ||
| Kura Oncology | ||
| C4 Therapeutics | ||
| Fate Therapeutics | ||
| Nektar Therapeutics | ||
| Lyell Immunopharma | ||
| Day One Biopharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Erasca | Not disclosed | Not disclosed |
| ImmunoGen, Inc. | Not disclosed | Not disclosed |
| Merus N.V. | Not disclosed | Not disclosed |
| Mirati Therapeutics, Inc. | Not disclosed | Not disclosed |
| Sana Biotechnology | Not disclosed | Not disclosed |
| Springworks Therapeutics, Inc. | Not disclosed | Not disclosed |
| TG Therapeutics | Not disclosed | Not disclosed |
23 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.